Emergent BioSolutions Inc. 2026 Annual Meeting of Stockholders

Emergent BioSolutions Inc. held its 2026 annual meeting of stockholders on April 29, 2026. Approximately 78.12% of the outstanding shares were represented. Stockholders elected four Class II directors, ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026, approved, on an advisory basis, the 2025 compensation of named executive officers, and approved an amendment to the Stock Incentive Plan to increase the number of shares available. The meeting also included the approval of the Amended and Restated Stock Incentive Plan, which increases the total number of shares available for awards and adjusts the share counting mechanism for different award types. The plan details eligibility, administration, stock availability, and provisions for stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock-unit awards, including adjustments for corporate events and changes in control.